Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271463
Max Phase: Preclinical
Molecular Formula: C56H67N5O8S2
Molecular Weight: 1002.31
Associated Items:
ID: ALA5271463
Max Phase: Preclinical
Molecular Formula: C56H67N5O8S2
Molecular Weight: 1002.31
Associated Items:
Canonical SMILES: CCN(CCCCCCCC(=O)NC(C(=O)N1C[C@@H](O)C[C@@H]1C(=O)N[C@H](C)c1ccc(-c2scnc2C)cc1)C(C)(C)C)CCOc1ccc(C(=O)c2c(-c3ccc(O)cc3)sc3cc(O)ccc23)cc1
Standard InChI: InChI=1S/C56H67N5O8S2/c1-7-60(29-30-69-44-25-20-38(21-26-44)50(66)49-45-27-24-42(63)32-47(45)71-52(49)40-18-22-41(62)23-19-40)28-12-10-8-9-11-13-48(65)59-53(56(4,5)6)55(68)61-33-43(64)31-46(61)54(67)58-35(2)37-14-16-39(17-15-37)51-36(3)57-34-70-51/h14-27,32,34-35,43,46,53,62-64H,7-13,28-31,33H2,1-6H3,(H,58,67)(H,59,65)/t35-,43+,46-,53?/m1/s1
Standard InChI Key: FIPBCTVJSYVOLS-PQCJVEOSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1002.31 | Molecular Weight (Monoisotopic): 1001.4431 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Li D, Yu D, Li Y, Yang R.. (2022) A bibliometric analysis of PROTAC from 2001 to 2021., 244 [PMID:36274273] [10.1016/j.ejmech.2022.114838] |
Source(1):